Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant.

Saved in:
Bibliographic Details
Main Authors: Busch, Catharina (Author) , Fraser-Bell, Samantha (Author) , Iglicki, Matias (Author) , Lupidi, Marco (Author) , Couturier, Aude (Author) , Chaikitmongkol, Voraporn (Author) , Giancipoli, Ermete (Author) , Rodríguez-Valdés, Patricio J. (Author) , Gabrielle, Pierre-Henry (Author) , Laíns, Inês (Author) , Santos, Ana Rita (Author) , Cebeci, Zafer (Author) , Amphornphruet, Atchara (Author) , Degenhardt, Valentin (Author) , Unterlauft, Jan-Darius (Author) , Cagini, Carlo (Author) , Mané-Tauty, Valérie (Author) , D’Amico Ricci, Giuseppe (Author) , Hindi, Isaac (Author) , Agrawal, Kushal (Author) , Chhablani, Jay (Author) , Loewenstein, Anat (Author) , Zur, Dinah (Author) , Rehak, Matus (Author)
Format: Article (Journal)
Language:English
Published: 21 September 2019
In: Acta diabetologica
Year: 2019, Volume: 56, Issue: 12, Pages: 1341-1350
ISSN:1432-5233
DOI:10.1007/s00592-019-01416-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00592-019-01416-4
Get full text
Author Notes:Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, Marco Lupidi, Aude Couturier, Voraporn Chaikitmongkol, Ermete Giancipoli, Patricio J. Rodríguez-Valdés, Pierre-Henry Gabrielle, Inês Laíns, Ana Rita Santos, Zafer Cebeci, Atchara Amphornphruet, Valentin Degenhardt, Jan-Darius Unterlauft, Carlo Cagini, Valérie Mané-Tauty, Giuseppe D’Amico Ricci, Isaac Hindi, Kushal Agrawal, Jay Chhablani, Anat Loewenstein, Dinah Zur, Matus Rehak, for the International Retina Group
Description
Summary:To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant.
Item Description:Gesehen am 06.03.2020
Physical Description:Online Resource
ISSN:1432-5233
DOI:10.1007/s00592-019-01416-4